100 related articles for article (PubMed ID: 7746498)
1. Non-competitive NMDA antagonists, FR115427 and MK801, enhance neuronal survival in primary culture.
Ueda Y; Katsuta K; Nakanishi H; Yoshida K
Neurosci Lett; 1995 Feb; 185(2):107-10. PubMed ID: 7746498
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
Sharkey J; Ritchie IM; Butcher SP; Kelly JS
Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
[TBL] [Abstract][Full Text] [Related]
3. Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
Nakanishi H; Katsuta K; Ueda Y; Takasugi H; Kuno A; Ohkubo M; Ogita K; Yoneda Y; Shirakawa K; Yoshida K
Psychopharmacology (Berl); 1995 Jan; 117(2):172-7. PubMed ID: 7753964
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.
Hodgkiss JP; Sherriffs HJ; Cottrell DA; Shirakawa K; Kelly JS; Kuno A; Ohkubo M; Butcher SP; Olverman HJ
Eur J Pharmacol; 1993 Aug; 240(2-3):219-27. PubMed ID: 7902282
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the binding of [3H]FR115427, a novel non-competitive NMDA receptor antagonist, to rat brain membranes.
Sherriffs HJ; Shirakawa K; Kelly JS; Olverman HJ; Kuno A; Okubo M; Butcher SP
Eur J Pharmacol; 1993 Nov; 247(3):319-24. PubMed ID: 8307103
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of FR115427 against ischemic hippocampal damage in gerbils.
Nakanishi H; Katsuta K; Koide T; Ueda Y; Shirakawa K; Yoshida K
Jpn J Pharmacol; 1994 Mar; 64(3):189-93. PubMed ID: 8022120
[TBL] [Abstract][Full Text] [Related]
7. Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists.
Ohkubo M; Kuno A; Katsuta K; Ueda Y; Shirakawa K; Nakanishi H; Nakanishi I; Kinoshita T; Takasugi H
Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):95-102. PubMed ID: 8582046
[TBL] [Abstract][Full Text] [Related]
8. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
Sharkey J; Ritchie IM; Butcher SP; Kelly JS
Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
[TBL] [Abstract][Full Text] [Related]
10. Involvement of AMPA/kainate-excitotoxicity in MK801-induced neuronal death in the retrosplenial cortex.
Bender C; Rassetto M; de Olmos JS; de Olmos S; Lorenzo A
Neuroscience; 2010 Aug; 169(2):720-32. PubMed ID: 20457221
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
[TBL] [Abstract][Full Text] [Related]
12. [The influencing actions of NMDA, MK801 and Ca(2+) on cultured retinal neuron cells].
Liu H; Ge J; Yang Z; Zhuo Y; Lin M
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):148-50. PubMed ID: 11955318
[TBL] [Abstract][Full Text] [Related]
13. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape.
Fiumelli H; Riederer IM; Martin JL; Riederer BM
Cell Motil Cytoskeleton; 2008 Jun; 65(6):495-504. PubMed ID: 18412220
[TBL] [Abstract][Full Text] [Related]
15. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
[TBL] [Abstract][Full Text] [Related]
16. Cell type-specific pharmacology of NMDA receptors using masked MK801.
Yang Y; Lee P; Sternson SM
Elife; 2015 Sep; 4():. PubMed ID: 26359633
[TBL] [Abstract][Full Text] [Related]
17. Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons.
Lin Y; Fossom LH; Skolnick P; Long JB
Eur J Pharmacol; 1998 Sep; 356(2-3):255-60. PubMed ID: 9774257
[TBL] [Abstract][Full Text] [Related]
18. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
Lecourtier L; Homayoun H; Tamagnan G; Moghaddam B
Biol Psychiatry; 2007 Oct; 62(7):739-46. PubMed ID: 17511968
[TBL] [Abstract][Full Text] [Related]
19. N-Methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture.
Hwang JY; Kim YH; Ahn YH; Wie MB; Koh JY
Exp Neurol; 1999 Sep; 159(1):124-30. PubMed ID: 10486181
[TBL] [Abstract][Full Text] [Related]
20. Small Aβ1-42 oligomer-induced membrane depolarization of neuronal and microglial cells: role of N-methyl-D-aspartate receptors.
Morkuniene R; Cizas P; Jankeviciute S; Petrolis R; Arandarcikaite O; Krisciukaitis A; Borutaite V
J Neurosci Res; 2015 Mar; 93(3):475-86. PubMed ID: 25400096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
